These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27868150)

  • 1. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
    Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
    Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
    Keijsers RR; Joosten I; Hendriks AG; Koenen HJ; van Erp PE; van de Kerkhof PC
    Exp Dermatol; 2015 Jan; 24(1):65-7. PubMed ID: 25355140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model.
    Satake K; Amano T; Okamoto T
    Sci Rep; 2019 Nov; 9(1):16322. PubMed ID: 31705000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
    Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
    Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions.
    Dyring-Andersen B; Bonefeld CM; Bzorek M; Løvendorf MB; Lauritsen JP; Skov L; Geisler C
    Scand J Immunol; 2015 Jul; 82(1):84-91. PubMed ID: 25904071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
    Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
    Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
    Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
    G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vitamin D
    Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
    J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Th17 cell fluctuation in psoriatic patients treated with topical calcipotriol and betamethasone butyrate propionate.
    Hino R; Kabashima R; Kawakami C; Sugita K; Nakamura M; Tokura Y
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):242-4. PubMed ID: 20477915
    [No Abstract]   [Full Text] [Related]  

  • 14. A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
    Duvetorp A; Levin LÅ; Engerstedt Mattsson E; Ryttig L
    Acta Derm Venereol; 2019 Apr; 99(4):393-399. PubMed ID: 30628631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
    Røpke M; Bulai Livideanu C; Kaldate R; Snel A; Paul C
    Br J Dermatol; 2018 Jan; 178(1):e33-e34. PubMed ID: 28722136
    [No Abstract]   [Full Text] [Related]  

  • 16. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
    Freeman K
    Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW; Houwing R; Sindrup JH; Wigchert S
    Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
    Tan ES; Oon HH
    Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
    [No Abstract]   [Full Text] [Related]  

  • 20. A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.
    Lu L; Xuan M; Yan Y; Li G; Zhou L; Wen Z; Lu C
    Trials; 2016 Oct; 17(1):482. PubMed ID: 27716422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.